Letters
Industry funding of patients' support groups: Objectives of patients, clinicians, and industry are similar
BMJ 2003; 327 doi: https://doi.org/10.1136/bmj.327.7410.343-c (Published 07 August 2003) Cite this as: BMJ 2003;327:343- Peter M Lapsley (plapsley@eczema.org), chief executive
- Skin Care Campaign, London N19 5NA
EDITOR—As the British umbrella organisation representing the interests of all people with skin diseases and their patients' groups, the Skin Care Campaign welcomed the balanced approach taken by Herxheimer in his article on the relationship between the pharmaceutical industry and patients' organisations.1 However, we contest the argument that industry will if nothing else influence policy if it directly …
Log in
Log in using your username and password
Log in through your institution
Subscribe from £173 *
Subscribe and get access to all BMJ articles, and much more.
* For online subscription
Access this article for 1 day for:
£38 / $45 / €42 (excludes VAT)
You can download a PDF version for your personal record.